Phosplatin Therapeutics   Report issue

For profit Phase 2
Founded: New York NY United States (2010)

Organization Overview

First Clinical Trial
2014
NCT02266745
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Phosplatin Therapeutics